Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. Its product offerings include treatment for depression, erectile dysfunction, high cholesterol, human immunodeficiency virus infection, hypertension, bacterial infections and systemic fungal infections, and other chronic therapeutic which includes pain, respiratory, vitamins or minerals, hospital anti-infectives, neurosciences, and cardiovascular. The firm's products include Prevenar 13, Ativan, Zosyn, Minipress XL, Meronem, Enbrel, Dolonex, Magnex, Trulimax, Neksium, Becosules, Gelusil, Mucaine, Folvite, Autrin, Citralka, and Corex Range. It operates through the India and Outside of India geographical segments. The company was founded on November 21, 1950 and is headquartered in Mumbai, India.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1,768
Frequently Asked Questions
What is Market Cap of Pfizer Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pfizer Ltd. market cap is 236.4B.
What is the 52-week high for Pfizer Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pfizer Ltd. 52 week high is 6,042.59 as of September 11, 2025.
What is the 52-week low for Pfizer Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pfizer Ltd. 52 week low is 3,618.77 as of September 11, 2025.
What is Pfizer Ltd. stock price today?
Pfizer Ltd. stock price today is 5,167.00.
What was Pfizer Ltd. stock price yesterday?
Pfizer Ltd. stock price yesterday was 5,142.00.
What is the PE ratio of Pfizer Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pfizer Ltd.’s P/E ratio is 29.23.
What is the Price-to-Book ratio of Pfizer Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pfizer Ltd. P/B ratio is 5.6054.
What is the 50-day moving average of Pfizer Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pfizer Ltd. 50-day moving average is 5,321.84.